These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11226565)

  • 1. A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA.
    Aberham C; Pendl C; Gross P; Zerlauth G; Gessner M
    J Virol Methods; 2001 Apr; 92(2):183-91. PubMed ID: 11226565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.
    Hokynar K; Norja P; Laitinen H; Palomäki P; Garbarg-Chenon A; Ranki A; Hedman K; Söderlund-Venermo M
    J Clin Microbiol; 2004 May; 42(5):2013-9. PubMed ID: 15131163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
    Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
    J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
    Baylis SA; Shah N; Minor PD
    J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory.
    Manaresi E; Gallinella G; Zuffi E; Bonvicini F; Zerbini M; Musiani M
    J Med Virol; 2002 Jun; 67(2):275-81. PubMed ID: 11992590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an improved method of detection of infectious parvovirus B19.
    Wong S; Brown KE
    J Clin Virol; 2006 Apr; 35(4):407-13. PubMed ID: 16455300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of B19 virus contamination in plasma pools for manufacturing, by using a competitive polymerase chain reaction assay.
    Gallinella G; Moretti E; Nardi G; Zuffi E; Bonvicini F; Bucci E; Musiani M; Zerbini M
    Vox Sang; 2002 Nov; 83(4):324-31. PubMed ID: 12437519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
    Kleinman SH; Glynn SA; Lee TH; Tobler L; Montalvo L; Todd D; Kiss JE; Shyamala V; Busch MP;
    Transfusion; 2007 Oct; 47(10):1756-64. PubMed ID: 17880600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
    Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E
    Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA.
    Donoso Mantke O; Nitsche A; Meyer R; Klingel K; Niedrig M
    J Clin Virol; 2004 Sep; 31(1):32-9. PubMed ID: 15288611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of B19 parvovirus in plasma pools before solvent-detergent treatment of plasma: AFSSAPS and EFS Aquitaine-Limousin's experience].
    Petermann R; Piquet Y; Lapeyre M; Goujon N; Gauthier M; Lalanne V; Mouillot L; Tissier MH; Boiron JM
    Transfus Clin Biol; 2010 Apr; 17(2):54-62. PubMed ID: 20674438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
    Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
    J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.
    Thomas I; Di Giambattista M; Gérard C; Mathys E; Hougardy V; Latour B; Branckaert T; Laub R
    Vox Sang; 2003 May; 84(4):300-7. PubMed ID: 12757504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation.
    Aubin JT; Defer C; Vidaud M; Maniez Montreuil M; Flan B
    Vox Sang; 2000; 78(1):7-12. PubMed ID: 10729805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of a PCR-ELISA in serum samples: diagnosis of active parvovirus B19 infection.
    Zerbini M; Gallinella G; Manaresi E; Musiani M; Gentilomi G; Venturoli S
    J Med Virol; 1999 Oct; 59(2):239-44. PubMed ID: 10459163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity PCR detection of parvovirus B19 in plasma.
    Daly P; Corcoran A; Mahon BP; Doyle S
    J Clin Microbiol; 2002 Jun; 40(6):1958-62. PubMed ID: 12037048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical- and PCR-based assay for the reproducible, routine detection of erythrovirus B19 in thyroid tissues.
    Page C; Hoffmann TW; Benzerdjeb N; Desailloud R; Sevestre H; Duverlie G
    J Med Virol; 2015 Jun; 87(6):1054-9. PubMed ID: 25754116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates.
    Schalasta G; Schmid M; Lachmund T; Enders G
    J Med Virol; 2004 May; 73(1):54-9. PubMed ID: 15042648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
    Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
    J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyramide signal amplification of biotinylated probe in dot-blot hybridization assay for the detection of parvovirus B19 DNA in serum samples.
    Zerbini M; Cricca M; Gentilomi G; Venturoli S; Gallinella G; Musiani M
    Clin Chim Acta; 2000 Dec; 302(1-2):79-87. PubMed ID: 11074066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.